The 114th annual meeting sees the introduction of a new  programme format featuring:

Five symposia focusing on key interdisciplinary translational themes:

Infectious diseases – into the Future

Diagnosis by DNA

~ in partnership with

Biochemical Society

Big Data in Clinical Research

New Targets in Cellular Metabolism

~ in partnership with

Open Theme

Infectious diseases – into the Future

The Osler Lecture

“Vaccines: An achievement of civilization, a human right, our health insurance for the future”

Dr Rino Rappuoli – Chief Scientist and Head External R&D, GSK Vaccines

Plenary Lecture

“Viral Hepatitis – towards elimination: vaccine or treat?”

Professor Ellie Barnes – Professor of Hepatology and Experimental Medicine, Nuffield, Department of Medicine, Oxford University

Diagnosis by DNA

~ in partnership with

Biochemical Society

The George Griffin Lecture

“Circulating DNA in health and disease”

Professor Dennis Lo – Director – Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong

Plenary Lecture

Professor Lyn Chitty – Professor of Genetics and Fetal Medicine, Chair at the Institute of Child Health, University College London, Consultant, University College Hospital NHS Foundation Trust

Big Data in Clinical Research

Key Note Plenary Lecture

“Large-scale clinical research and the digital revolution”

Professor Martin Landray – Deputy Director of Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, University of Oxford

Plenary Lecture

“Big data and cancer: The establishment of the UK Colorectal Cancer Intelligence Hub”

Professor Eva Morris – Professor of Cancer Epidemiology, and lead, Cancer Epidemiology Group, University of Leeds

New Targets in Cellular Metabolism

~ in partnership with

Key Note Plenary Lecture

“Understanding cellular oxygen sensing mechanisms: implications for medicine”

Professor Sir Peter Ratcliffe Nobel Prize for Medicine 2019 – Director, Target Discovery Institute, University of Oxford

Plenary Lecture

“Drugging the cancer genome, the cancer state, and cancer evolution and drug resistance”

Professor Paul Workman – Chief Executive and President of The Institute of Cancer Research, London

After Dinner Speaker

Professor Sir John Bell – Regius Professor of Medicine at Oxford University, and Chairman of the Office for the Strategic Coordination of Health Research

Each symposia will feature oral scientific abstracts and flash poster presentations